Oct 23 (Reuters) - INVO Bioscience Inc INVO.O :
* INVO BIOSCIENCE AND NAYA BIOSCIENCES ANNOUNCE DEFINITIVE
MERGER
AGREEMENT TO ESTABLISH EXPANDED PUBLICLY TRADED LIFE SCIENCE
COMPANY
* INVO BIOSCIENCE INC - UNDER TERMS OF AGREEMENT, NAYA
BIOSCIENCES' SHAREHOLDERS WILL RECEIVE 7.3333 SHARES OF INVO FOR
EACH SHARE OF NAYA BIOSCIENCES AT CLOSING
* INVO BIOSCIENCE INC - COMBINED COMPANY IS EXPECTED TO
OPERATE
UNDER NAME "NAYA BIOSCIENCES"
* INVO BIOSCIENCE INC - COMBINED COMPANY IS EXPECTED TO
OPERATE
UNDER NAME "NAYA BIOSCIENCES"
* INVO BIOSCIENCE INC - DANIEL TEPER, CURRENTLY CHAIRMAN &
CEO OF
NAYA BIOSCIENCES, WILL BE NAMED CHAIRMAN & CEO OF COMBINED
COMPANY
* INVO BIOSCIENCE INC - MERGER TARGET VALUATION IS $12.4
MILLION
FOR INVO AND ABOUT $91 MILLION FOR NAYA, BASED ON A TARGET STOCK
PRICE OF $5.00 PER SHARE
* INVO BIOSCIENCE INC - MERGER HAS BEEN UNANIMOUSLY APPROVED
BY
BOARD OF DIRECTORS OF EACH COMPANY
* INVO BIOSCIENCE INC - BOARD OF DIRECTORS OF COMBINED
COMPANY
WILL HAVE SIX (6) DIRECTORS NOMINATED BY NAYA AND ONE (1)
DIRECTOR NOMINATED BY INVO
* INVO BIOSCIENCE INC - MERGER IS EXPECTED TO CLOSE IN Q4
OF 2023
Source text for Eikon: ID:nPnd1qXZa
Further company coverage: INVO.O
((Reuters.Briefs@thomsonreuters.com;))